Open AccessTreatment of Colorectal Cancer with and without Bevacizumab: A Phase III Study
Author(s) -
George P. Stathopoulos,
C. Batziou,
Dimitrios T. Trafalis,
J. Koutantos,
Spyros Batzios,
J. Stathopoulos,
J. Legakis,
Athanasios Armakolas
Publication year - 2010
Publication title -
oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.987
H-Index - 98
eISSN - 1423-0232
pISSN - 0030-2414
DOI - 10.1159/000320520
Subject(s) - medicine , bevacizumab , irinotecan , colorectal cancer , gastroenterology , chemotherapy , surgery , fluorouracil , proteinuria , cancer , kidney
The objective of this phase III trial was to compare chemotherapy combined with bevacizumab versus chemotherapy alone in the treatment of patients with advanced colorectal cancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom